
Desmoplastic melanoma patients show a remarkable response to neoadjuvant pembrolizumab, avoiding postoperative radiation therapy.


coremsg

Desmoplastic melanoma, an often deeply invasive disease occurring in older adults, showed a uniquely favorable response to neoadjuvant pembrolizumab in this small study.

'Astounding' Response to Neoadjuvant Desmoplastic Melanoma Tx

response-to-neoadjuvant-pembrolizumab-in-desmoplastic-melanoma


Response to Neoadjuvant Pembrolizumab in Desmoplastic Melanoma
